These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 22760479)

  • 1. Optimization of pharmacotherapy in chronic heart failure: is heart rate adequately addressed?
    Franke J; Wolter JS; Meme L; Keppler J; Tschierschke R; Katus HA; Zugck C
    Clin Res Cardiol; 2013 Jan; 102(1):23-31. PubMed ID: 22760479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ["3P (Patient-Pulse-Prognosis) in heart failure" survey: focus on heart rate].
    Dúbrava J
    Vnitr Lek; 2016 Jan; 62(1):17-24. PubMed ID: 26967233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-life indications to ivabradine treatment for heart rate optimization in patients with chronic systolic heart failure.
    Tondi L; Fragasso G; Spoladore R; Pinto G; Gemma M; Slavich M; Godino C; Salerno A; Montanaro C; Margonato A
    J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):351-356. PubMed ID: 29762337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of Heart Rate and Beta-Blocker Use in Sinus Rhythm in Patients with Heart Failure and Preserved Ejection Fraction.
    Li S; Li X
    High Blood Press Cardiovasc Prev; 2019 Oct; 26(5):405-411. PubMed ID: 31625118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of heart rate in elderly with systolic heart failure and concomitant atrial fibrillation.
    Barywani S; Petzold M
    Scand Cardiovasc J; 2017 Aug; 51(4):190-196. PubMed ID: 28393567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of home patient telemonitoring on use of β-blockers in congestive heart failure.
    Antonicelli R; Mazzanti I; Abbatecola AM; Parati G
    Drugs Aging; 2010 Oct; 27(10):801-5. PubMed ID: 20883060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blocker target dosing and tolerability in a dedicated heart failure clinic in Johannesburg.
    Bolon J; McCutcheon K; Klug E; Smith D; Manga P
    Cardiovasc J Afr; 2019 Mar/Apr 23; 30(2):103-107. PubMed ID: 30740613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ivabradine for Treatment of Heart Failure with Preserved Ejection Fraction].
    Babushkina GV; Shaikhlislamova GI
    Kardiologiia; 2020 Oct; 60(10):33-37. PubMed ID: 33228503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription of cardiovascular drugs in the French ODIN cohort of heart failure patients according to age and type of chronic heart failure.
    Juillière Y; Suty-Selton C; Riant E; Darracq JP; Dellinger A; Labarre JP; Druelle J; Mulak G; Danchin N; Jourdain P;
    Arch Cardiovasc Dis; 2014 Jan; 107(1):21-32. PubMed ID: 24388162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Heart rate control in chronic heart failure patients received cardiovascular implantable electronic device therapy: effects of optimized medication].
    Gao Y; Liang YC; Yu HB; Yan XL; Xu BG; Liu R; Wang N; Xu GQ; Wang ZL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Mar; 46(3):173-177. PubMed ID: 29562420
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
    Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
    Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart rate reduction and exercise performance in recent onset heart failure with reduced ejection fraction: arguments for beta-blocker hypo-response.
    Verbrugge FH; Vrijsen J; Vercammen J; Grieten L; Dupont M; Mullens W
    Acta Cardiol; 2015 Oct; 70(5):565-72. PubMed ID: 26567816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ivabradine improves quality of life in subjects with chronic heart failure compared to treatment with β-blockers: results of a multicentric observational APULIA study.
    Riccioni G; Masciocco L; Benvenuto A; Saracino P; De Viti D; Massari F; Meliota G; Buta F; Speziale G
    Pharmacology; 2013; 92(5-6):276-80. PubMed ID: 24296869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study.
    Böhm M; Borer J; Ford I; Gonzalez-Juanatey JR; Komajda M; Lopez-Sendon J; Reil JC; Swedberg K; Tavazzi L
    Clin Res Cardiol; 2013 Jan; 102(1):11-22. PubMed ID: 22575988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivabradine treatment in a chronic heart failure patient cohort: symptom reduction and improvement in quality of life in clinical practice.
    Zugck C; Martinka P; Stöckl G
    Adv Ther; 2014 Sep; 31(9):961-74. PubMed ID: 25160945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A regional quality improvement effort to increase beta blocker administration before vascular surgery.
    Goodney PP; Eldrup-Jorgensen J; Nolan BW; Bertges DJ; Likosky DS; Cronenwett JL;
    J Vasc Surg; 2011 May; 53(5):1316-1328.e1; discussion 1327-8. PubMed ID: 21334166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BETAWIN-AHF study: effect of beta-blocker withdrawal during acute decompensation in patients with chronic heart failure.
    Miró Ò; Müller C; Martín-Sánchez FJ; Bueno H; Mebazaa A; Herrero P; Jacob J; Gil V; Escoda R; Llorens P;
    Clin Res Cardiol; 2016 Dec; 105(12):1021-1029. PubMed ID: 27379611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction.
    Park CS; Park JJ; Mebazaa A; Oh IY; Park HA; Cho HJ; Lee HY; Kim KH; Yoo BS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ
    J Am Heart Assoc; 2019 Mar; 8(6):e011077. PubMed ID: 30845873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Blockade in Heart Failure With Reduced Ejection Fraction: Does Heart Rate Control Influence Readmissions?
    Owens RE; Twilla JD; Self TH; Alshaya AI; Metra CJ; Cummings C; Oliphant CS
    J Pharm Pract; 2018 Feb; 31(1):40-45. PubMed ID: 28737066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.